Conférences  >  Médecine & Soins de Santé  >  Pharmacologie et développement des médicaments  >  Royaume-Uni

Oxford Global Conferences

A two-day event packed with leading speakers, research and cutting-edge presentations on the latest advancements in cancer immunotherapy, with dedicated sessions on different therapeutic modalities as well as case studies on innovative preclinical and translational tools.

Tél.: [+441865 248455];     Email.: b.westmore@oxfordglobal.co.uk

Discovery & Development: Cell & Combination Therapies, Biomarkers & Precision Medicine In Immuno-Oncology, Autoimmunity Mechanisms & Novel Treatments, Discovery & Development: Intratumoral Immunotherapies & Antibody Therapies, Translational Development, Preclinical & Clinical Development

Oxford Global Conferences

Engage with esteemed pharmaceutical & biotech representatives as well as thought-leaders from academic & research institutions onsite and benefit from attending over 60 presentations. We will be welcoming onsite over 300 delegates for two days of cutting-edge scientific sessions and case studies bringing the latest biologics developments to the forefront of research.

Oxford Global Conferences;     Tél.: [+44 1865 248455];     Email.: info@oxfordglobal.co.uk

Antibody-Based Molecular Engineering, Emerging Techniques for Bioanalysis & Characterisation and Quality Control Systems, Track 1: Computational Tools, AI/ML & Structural Approaches & inEngineering, Multi Specific Antibodies, Cell Engagers & Other New Modalities

Royal Society of Chemistry (RSC)

With more than 70 FDA-approved small molecules, the field of kinase inhibition continues to attract significant investment from the drug discovery and development community. The 10th SCI/RSC symposium on kinases will encompass plenary lectures on emergent topics and case studies of ongoing programmes as well as successful past programmes. A range of topics including new screening approaches, brain penetrant kinase inhibitors, induced protein degradation, allosteric inhibitors and kinase inhibition for immuno-oncology will be covered, along with views and perspectives on the future of kinase inhibitor research.

Oxford Global

Learn from and meet leading experts in pharmaceutical science, addressing the critical strategic advances and technical innovation in formulation, drug delivery and drug product development.

Oxford Global;     Tél.: [+441865248455];     Email.: l.ahmed@oxfordglobal.co.uk

Formulation, Drug Delivery, Drug Product Development, Therapeutic Modalities

Oxford Global

Join and network with over 400 industry leaders at the renowned Drug Discovery Summit in Berlin, where we will address the latest advancements in target identification, validation and HIT optimisation.

Oxford Global;     Tél.: [+441865248455];     Email.: h.liddiard@oxfordglobal.co.uk

Phenotypic, Medicinal Chemistry, Novel Targets, Disease Modelling, Chip Development, Genomic Strategies, Chemical Biology, Drug Design, Chemical Modalities

Oxford Global Conferences

An intensive 2-day meeting that delves into the latest in advancements in FAIR data, data analytics, AI and machine learning technologies in pharma, as well as latest advancements in the adoption of innovative & digital health technologies, high-performance medicine and digital biomarkers

Oxford Global Conferences;     Tél.: [+44 1865 248455];     Email.: h.liddiard@oxfordglobal.co.uk

PharmaTec, Digital Medicine, Data Analytics, AI, Digital Health Technologies, Data Automation, Computational Biology Applications, Digital Health, Digital Therapeutics, Precision Medicine, Digital Biomarkers

Royal Society of Chemistry (RSC)

The aim of the 8th RSC-BMCS Fragment-based Drug Discovery meeting will be to continue the focus on case studies in Fragment-based Drug Discovery that have delivered compounds to late stage medicinal chemistry, preclinical or clinical programmes. The Fragment series was started in 2007 and continues with this theme in having over three-quarters of the presentations focused on case studies. This will be complemented by technology progress in high concentration, NMR, SPR and X-ray screening.